We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease (GREEN MEMORY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04520412
Recruitment Status : Suspended (The quality of study was seriously affected by the COVID-19, so it was decided to suspend the trial and restart it at the right time.)
First Posted : August 20, 2020
Last Update Posted : November 23, 2022
Information provided by (Responsible Party):
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : December 2025
Estimated Study Completion Date : October 2026